Core Viewpoint - The company ROMOSS has initiated a recall of certain models of its power banks due to potential safety hazards related to overheating and fire risks, affecting a total of 491,745 units manufactured between June 5, 2023, and July 31, 2024 [1][2]. Group 1: Recall Details - The recall includes three models: PAC20-272 (331,578 units), PAC20-392 (113,253 units), and PLT20A-152 (46,914 units) [1]. - The affected production batches for PAC20-272 were manufactured between June 5, 2023, and July 28, 2023, and January 5, 2024, to February 8, 2024 [1]. - For PAC20-392, the manufacturing dates are from June 23, 2024, to July 31, 2024, while PLT20A-152 was produced from August 2023 to January 2024 [1]. Group 2: Safety Measures - The company will provide consumers with a free replacement power bank of equal or greater value or offer a refund to eliminate safety concerns [2]. - The recall was prompted by issues with raw materials used in battery cells, which could lead to overheating and potential fire hazards in extreme conditions [2]. Group 3: Public Response and Commitment - In response to recent discussions regarding the ban of ROMOSS power banks in several universities in Beijing, the company issued an apology and committed to taking full responsibility for any defective products identified by authoritative agencies [3][5]. - The company emphasized its commitment to safety and quality control, stating that all products meet national and international safety standards [5].

Core Viewpoint - L'Oréal has recalled all batches of its Effaclar Duo acne treatment product in the US due to the detection of trace amounts of benzene, a recognized carcinogen, although the recall does not affect the Chinese market [1][2]. Group 1: Product Recall Details - The recall is limited to the US and Canada, with L'Oréal confirming that the product containing benzoyl peroxide (BPO) is not sold in China [1]. - This incident marks the second occurrence of benzene-related issues for L'Oréal products this year [1]. Group 2: Product Composition and Safety - The main ingredient in Effaclar Duo is benzoyl peroxide, which can lead to the formation of benzene due to its instability [1]. - The National Medical Products Administration of China has prohibited the use of benzoyl peroxide in cosmetics since May 2021 [1]. Group 3: Consumer Safety Commitment - L'Oréal has stated its commitment to consumer safety and has been working closely with the FDA to address the issue [2]. - The company has faced multiple class-action lawsuits in the US regarding other BPO acne treatment products, but maintains that all its products undergo strict quality control and safety testing [2].